soul trial oral semaglutide cardiovascular outcomes nejm 2025 results 2024 Oral Semaglutide's Impact on Cardiovascular Events in Type 2 Diabetes Patients with Cardiovascular and Kidney Disease: SOUL Trial Results Canadian Perspectives 2025 Whiteboard on

The studies showed similar efficacy in men and women, which is important to note because many growth hormone-related compounds show sex-dependent responses

And being like, see, look at this amazing mechanism and look at these early results

The bupropion component can cause dry mouth, insomnia, and tremor in some patients

L-Carnitine picks up that fat and carries it to where your body burns it as energy so it doesn't go back

GLP-1 receptor agonist injectionsused for weight management and blood sugar controlcommonly cause gastrointestinal side effects such as nausea, vomiting, and constipation in the first 24 weeks of treatment

Eur J Endocrinol 130 : 224228 Bengtsson BA et al